|
⚲
|
| Keyboard |
| Dawes Karen A
✚
|
|
|---|---|
| CIK # | 0001261506 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001261506] | |
| 4 | [0001261506] | |
| 5 | [0001261506] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dawes Karen A | |
| Repligen Corp | |
| Barinthus Biotherapeutics PLC | |
| Depomed Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Repligen Corp RGEN
Common Stock
|
2025-12-17 | Sell | 275 | $161.00 | 44,275 |
|
Barinthus Biotherapeutics PLC BRNS
Share Option (Right to Buy) · derivative
|
2025-06-10 | Grant | 20,174 | $0.00 | |
|
Repligen Corp RGEN
Common Stock
|
2025-05-15 | Grant | 973 | $0.00 | |
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2025-05-15 | Grant | 1,800 | $0.00 | |
|
Repligen Corp RGEN
Common Stock
|
2024-06-14 | Option exercise | 2,953 | $67.71 | 199,948 |
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2024-06-14 | Option exercise | 2,953 | $0.00 | |
|
Repligen Corp RGEN
Common Stock
|
2024-05-16 | Grant | 803 | $0.00 | |
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2024-05-16 | Grant | 1,576 | $0.00 | |
|
Barinthus Biotherapeutics PLC BRNS
Share Option (Right to Buy) · derivative
|
2024-05-10 | Grant | 19,516 | $0.00 | |
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2024-02-27 | Option exercise | 4,626 | $0.00 | |
|
Repligen Corp RGEN
Common Stock
|
2024-02-27 | Option exercise | 4,626 | $42.07 | 194,616 |
|
Repligen Corp RGEN
Common Stock
|
2024-02-27 | Sell | 1,000 | $193.35 | 193,350 |
|
Repligen Corp RGEN
Common Stock
|
2023-08-29 | Sell | 850 | $171.38 | 145,673 |
|
Repligen Corp RGEN
Common Stock
|
2023-08-29 | Option exercise | 7,392 | $18.12 | 133,943 |
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2023-08-29 | Option exercise | 7,392 | $0.00 | |
|
Repligen Corp RGEN
Common Stock
|
2023-05-18 | Grant | 798 | $0.00 | |
|
Repligen Corp RGEN
Stock Option (Right to Buy) · derivative
|
2023-05-18 | Grant | 1,730 | $0.00 | |
|
Barinthus Biotherapeutics PLC VACC
Share Option (Right to Buy) · derivative
|
2023-05-11 | Grant | 19,197 | $0.00 | |
|
Repligen Corp RGEN
Common Stock
|
2022-09-09 | Sell | 775 | $227.17 | 176,057 |
|
Barinthus Biotherapeutics PLC VACC
Share Option (Right to Buy) · derivative
|
2022-06-15 | Grant | 18,604 | $0.00 | |
| showing 20 of 163 most recent transactions | |||||